The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2019
Filed:
Jul. 24, 2018
Applicants:
Plexxikon Inc., Berkeley, CA (US);
Daiichi Sankyo Company, Limited, Tokyo, JP;
Inventors:
Prabha N. Ibrahim, Mountain View, CA (US);
Hamid Rezaei, Berkeley, CA (US);
Gary Conard Visor, Castro Valley, CA (US);
Tomoari Kamo, Tokyo, JP;
Hiroshi Yamakose, Tokyo, JP;
Assignees:
Plexxikon Inc., Berkeley, CA (US);
Daiichi Sankyo Company, Limited, Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 45/06 (2006.01); A61K 9/48 (2006.01); A61K 31/444 (2006.01); A61P 25/00 (2006.01); A61P 27/00 (2006.01); A61P 9/00 (2006.01); A61P 25/28 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 19/10 (2006.01); A61P 25/18 (2006.01); A61P 31/18 (2006.01); A61P 43/00 (2006.01); A61P 25/08 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/444 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61P 9/00 (2018.01); A61P 19/10 (2018.01); A61P 25/00 (2018.01); A61P 25/08 (2018.01); A61P 25/18 (2018.01); A61P 25/28 (2018.01); A61P 27/00 (2018.01); A61P 31/18 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 35/04 (2018.01); A61P 43/00 (2018.01); C07B 2200/13 (2013.01);
Abstract
Provided are compositions comprising Compound I having the following structure: or a pharmaceutically acceptable salt thereof, and a solubilizing agent; methods of making the same; and methods of using the same.